IU/Kg/wcck). CHBP was mca\urcd b) llPl C-gcl fillrnt~on and corrccllon was made forGH Ic\cls> 6 n & n l Rcsul~s of plasma Glllll'('i; ofradio3cl1\it))and 1Gf.1 lsvcls (nglml) arc cxprciscd as mean j SEM. ~o n n a~ values for age are: GHBP = 24.8 f 1 The basal GHBP level is low. A significant dccrcasc i n GHBP is found 6 h after the first injection of GH. 01 the 2 pattents (3 sampesi with posltrve ant,-GH Ab 10 the GH treated groups, only one had a reduction 10 growth rat0 (the Met GH palienil. lollowing tranrler to a mamrnal~an derived GH, resumplion of growth rate was ohsewed although ant#-GH antibody lller was not completely reduced
The presence of ants CCP At) in a11 groups includ~ng lllc control group suggests that thts determ#nat!on s of no value n tlle GH trcated chld Slncs We have recently demonstrated a correlation (r= 0.64; p<0 .0011 between nocturnal GH secretlon and plasma vltamlne A levels In 68 french short prepubertal chlldren ( aged 4 to 12 I wlthout organlc dlsease. 25 of these chlldren had a vltaminA/ Retlnol Elnding Proteln ratlo <0.6, pointlng to a relatlve vltamlne A deflclency. In order to assess the posslbillcy of an inadequate dietary vitamine A, vitamln A supply was estimated as mean dialy intake over a one year perlod In 56 shol-t chlldren compared to a group of age matched normal chlldren (n=56).Vitamine A Intake was slgnlflcantly lower(p<0.001) in chlldren wlth short stature(meaniSD 659+600 uG/day) as compared with normal chlldren. (1305 f 9 9 9 1 . Interestingly vltamln A. ~n t a k e was s l g n~f~c a n t l y (p<O.Olllower ( mean ? SD: 459i 1 9 2 ug/dayl In 10 chlldren with neurosecretory dysfunctlon, The v~t a m i n K-dependent coagulation factors II (prothrombin), VII (proconvertin). IX (Christmas-factor), and X (Stuart-factor) are all synthesized in the liver as proenzymes. The synthesis of other liver enzymes are affected by growth hormone (GH). To ~nvestigate whether GH aHects the synthesis or metabolism of coagulation factors, hypophysectomized (hypox) male rats were treated with GH (mini-osmotic pumps) or daily injections of cortisone, thyroxine, vitamin K or sal~ne (n=7-10). At day 11, all rats were cardlopunctured and the prothrombin complex (measures the activity of vitamin K-dependent coagulat~on factors), and the factors II, VII, IX, and X were determined. The prothromb~n complex was 52.911.2% for shamoperated rats and 39.1+0.8% for hypox rats receiving saline inject~ons (mean+SEM; p<0.001). All vitamin K-dependent coagulation factors were decreased after hypophysectomy. However, this was s~gnificant only for factor VII decreasing from 264k23 to 131+9% (p<0.001) and factor IX decreasing from 28.4k2.2 to 17.1+2.5% (p<O.Ol). When hypox rats were treated with GH, the prothrombin complex increased to 50.9L1.0 % (pc0.001, compared to 39.1+0.8%) and the factor VII increased to 299+10% (p<0.001. compared to 131+9%). All the other factors were normallzed after GH-treatment (dala not shown). The injection of cortisone, thyroxine, or vitamin K to hypox rats had no effect. It can be concluded that GH is of great importance for normal blood coagulation in the male rat. GH-deficiency causes a decrease In the levels of vltamin K-dependent coagulation factors, especially factor VII, and the prothrombin complex.
Mcdicinc. Universily of Hc~Jelberg, Gcnnany, and Dpt i f t'ed!amc*, Universily of Barel. Swimrland Supraphysiolog~cal doccs of IhGH are used for ueaunent of renal growlh fiulwc. Because of reduced renal MCR of rhGll lhls may mrult ~n accumulalion ofrhGll To determine the quanllly of rmrd and exuarcnal MCR ofrlrGII ~n chronic rend falure (CRD we Fdormed slcpwise steady-slaw inlusion sludtes ofrhGII in 12 p.ttienu (pb) with CRF(6adullr. 6 children: GFR range 8 to44 mUmin x 1.73 m2) and 24 healthy adull control\ (Co). Endogenous GI1 secretion was supprcrscd hy I.V. infusion of ocueoude (2 ugl1.73 m2 x h) I l G l l was ~nfused at three different rates, rciulting ~n mean plasma levels of 5 (11. 30 01) and 
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URINAKY GROWTH HORhIONE, its value in dldgnu~k and Illerapy rurvey of dicorders of CH secretion J Glrnrd and A N Ekrle, Dcpl of Rcswch, University Ilosp~lal Dasel, and I'edmmc Endoolnc Cllritc and Laboratory D m l GII-excretion in urinc har fonncrly been shown lo correlate with mc.m plasma levclr A psltlve correlauon wa? found belwccn lhc mean of 5-10 nlghl (firrt morning votd) and 24 hour samlpea.lnler-and tnulndiv~dual vanauon in young healthy adults.:ll)(l hned urine samples (4 hours) wllh an overdl mean of 830 pg/ d IIE ( range 78-2613 )had a vanauon of the mean of 10 %amples of 25% between Ihc individuals Thc inIra-individual "arialion or Ihe 10 samples was 40%.InjecUon or infusion (over 60 mifloles) of 1 mg of hiosyntheuc GI1 resulled In a mean plama level ovcr 90 minutes of 35 and 75 ugll respectively. Collecting urine over 240 minules = approximx~-I) I ? x TI2 gave a urine exncuon ofO.W? Wand 0.W24R of lhe mean plasma level for tnfuston and holus rerpectivcly 0 0006%. and 0.W8% oflhe towl amounl injccled was found in Ul e 4 hour ur 'c samplc A rclercncc range of urine GI1 w u established wilh a 25 percentile \,;filuc of 1.13 / 1.87 and 2 3 ngD4 hours and 0 4 10.62 and 1 0 ng/ntghl for UI C age group5 < 7 , 7-10112.5 and 10112.5 -18/19 years respecll~ely 1-3 years GII-therapy ~mproved hetght expressed as delL? height SDS by + 1.63 and 2.0 In paticnls wnlh preueaunent urinc GI1 Icvcls < p 50 ard < p 25 rcspeclivcly Rclaled lo mean plama nlghl profiles <or > 3 ug/l dclta hctght SDS was + 1.61 and + 2.2 hiean unnary gh cxcreoon comelawd wllf~ r = 0.5h wllh IGF 1 Ic\cls during uealrncnt.
In trcaled ~u c n t s 24 hr ~h exerelion on / off Ihcranv wcre in nc12-l hr :
several (Rst mommc) urines must he collcclcd Inlac1 renal 1uhul;v funcuon musl he assessed
